Olysio

­
  • olysio

Olysio

Facts of Olysio Simeprevir Capsules 150 mg ?

  • Medicine Name: OLYSIO
  • Generic Name: SIMEPREVIR
  • Date of Approval: 25.11.2013
  • Company Name: Johnson & Johnson's pharmaceutical division Janssen Pharmaceutica.
Category:

Product Description

What is Olysio Simeprevir Capsules 150 mg ?

Olysio is Indicated for treatment of chronic hepatitis C (CHC); efficacy has been established in combination with peginterferon alfa and ribavirin in patients with HCV genotype 1 infection with compensated liver disease (including cirrhosis)

What are OLYSIO safety information ?

OLYSIO should not be taken alone.

It is not known if OLYSIO is safe and effective in children under 18 years of age.

What are the indications and usage?

OLYSIO is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

  • OLYSIO efficacy has been established in combination with peginterferon alfa and ribavirin in HCV genotype 1 infected subjects with compensated liver disease (including cirrhosis).
  • OLYSIO must not be used as monotherapy.

Screening patients with HCV genotype 1a infection for the presence of virus with the NS3 Q80K polymorphism at baseline is strongly recommended. Alternative therapy should be considered for patients infected with HCV genotype 1a containing the Q80K polymorphism.

How supplied/storage and handling ?

OLYSIO (simeprevir) 150 mg capsules are white, marked with “TMC435 150” in black ink. The capsules are packaged into a bottle containing 28 capsules (NDC 59676‑225‑28) or a bottle of 7 capsules (emergency supply; NDC 59676‑225‑07).

Store OLYSIO capsules in the original bottle in order to protect from light. Store OLYSIO capsules at room temperature below 30°C (86°F).